Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial

Institutions:

• St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, United Kingdom
• Raphael Labs Limited, 6 Derby Street, London, W1J 7AD, United Kingdom
• Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, United Kingdom
• Danerius, LLC. Sarasota, FL, United States of America
• Department of Physiology, Anatomy and Genetics, University of Oxford, Sir Henry Wellcome Building of Gene Function, South Parks Road, Oxford, OX1 3PT, United Kingdom
• Chemistry Research Laboratory, Mansfield Road, Oxford, OX1 3TA, United Kingdom
• Manipal Hospital & Research Center, Mangalore, Karnataka, India
• TrialGunva Pvt. LTd, Bengaluru, Karnataka, India
• Department of Pulmonology, Atharva Multispeciality Hospital & Research Centre, Lucknow, Uttar Pradesh, India
• Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom
• Althea Lifesciences, Sahibabad, Uttar Pradesh, India
• Queen Mary University of London, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, EC1M 6BQ, United Kingdom